Mir Seyed Nazari, P.; Marosi, C.; Moik, F.; Riedl, J.; Özer, Ö.; Berghoff, A.S.; Preusser, M.; Hainfellner, J.A.; Pabinger, I.; Zlabinger, G.J.;
et al. Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma. Cancers 2019, 11, 2020.
https://doi.org/10.3390/cancers11122020
AMA Style
Mir Seyed Nazari P, Marosi C, Moik F, Riedl J, Özer Ö, Berghoff AS, Preusser M, Hainfellner JA, Pabinger I, Zlabinger GJ,
et al. Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma. Cancers. 2019; 11(12):2020.
https://doi.org/10.3390/cancers11122020
Chicago/Turabian Style
Mir Seyed Nazari, Pegah, Christine Marosi, Florian Moik, Julia Riedl, Öykü Özer, Anna Sophie Berghoff, Matthias Preusser, Johannes A. Hainfellner, Ingrid Pabinger, Gerhard J. Zlabinger,
and et al. 2019. "Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma" Cancers 11, no. 12: 2020.
https://doi.org/10.3390/cancers11122020
APA Style
Mir Seyed Nazari, P., Marosi, C., Moik, F., Riedl, J., Özer, Ö., Berghoff, A. S., Preusser, M., Hainfellner, J. A., Pabinger, I., Zlabinger, G. J., & Ay, C.
(2019). Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) are Associated with a High Risk of Venous Thromboembolism in Patients with Glioma. Cancers, 11(12), 2020.
https://doi.org/10.3390/cancers11122020
